Filing Details
- Accession Number:
- 0001437749-14-000043
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-02 16:02:42
- Reporting Period:
- 2014-01-02
- Filing Date:
- 2014-01-02
- Accepted Time:
- 2014-01-02 16:02:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1299139 | Tearlab Corp | TEAR | Surgical & Medical Instruments & Apparatus (3841) | 593434771 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1487348 | Paul Karpecki | 9980 Huennekens St., Ste 100 San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-01-02 | 3,376 | $3.12 | 6,876 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-01-02 | 548 | $2.59 | 7,424 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-01-02 | 1,076 | $2.11 | 8,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-01-02 | 5,000 | $9.47 | 3,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-01-02 | 3,376 | $0.00 | 3,376 | $3.12 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-01-02 | 548 | $0.00 | 548 | $2.59 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-01-02 | 1,076 | $0.00 | 1,076 | $2.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-12-12 | No | 4 | M | Direct | |
| 0 | 2020-04-01 | No | 4 | M | Direct | |
| 3,710 | 2020-07-01 | No | 4 | M | Direct |
Footnotes
- The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on April 2, 2013.
- Represents the weighted average share price of an aggregate total of 5,000 shares sold in the price range of $9.27 to $9.53 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- Twenty-five percent (25%) of the shares subject to the option vested and became exercisable on April 12, 2010, and, thereafter, one thirty sixth (1/36th) of the remaining shares subject to the option vested and became exercisable in equal monthly installments over the next thirty six (36) months.
- One hundred percent of the shares subject to the option vested and became exercisable on April 1, 2010.
- One hundred percent of the shares subject to the option vested and became exercisable on July 1, 2010.
Billionaire Hedge Funds
